Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 301-310 of 316 for Lung cancer

Edit search filters
  1. Immune Response to Antigens

    Jacksonville, FL

  2. A Study to Evaluate Fractionated Radiation Therapy Utilizing GRID Therapy for Locally-advanced Bulky Tumors

    Rochester, MN

  3. A Registry For People With Lung Cancer

    Rochester, MN

  4. A Study Identifying Predictive Biomarkers for the Progression of Invasive Squamous Cell Carcinoma

    Rochester, MN

  5. A Blood Collection Protocol to Study the Immune Responses of Cancer Patients with Malignancies

    Scottsdale/Phoenix, AZ, Rochester, MN

  6. Establishment of a Biorepository of Baseline and Follow-up Saliva Samples Collected from Newly Diagnosed, Treatment-naïve Cancer Patients

    Jacksonville, FL

  7. Longitudinal Lung Health Study

    Scottsdale/Phoenix, AZ, Rochester, MN

  8. Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

    Albert Lea, MN, Eau Claire, WI, La Crosse, WI, Mankato, MN

  9. Pre-Transplant Patients’ Experiences with Uncertainty

    Jacksonville, FL, Rochester, MN

  10. cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease (CAMPERR)

    Rochester, MN

.

Mayo Clinic Footer